Development of imaging therapeutic agent for hypoxic tumor
糖代謝診断の分子生物学的評価
Molecular Biological Evaluation of Glucose Metabolism Diagnosis
ミトコンドリア機能診断薬剤の開発
Development of Radiopharmaceutical for Mitochondrial Function diagnosis
Development of imaging therapeutic agent for hypoxic tumor
Molecular Biological Evaluation of Glucose Metabolism Diagnosis
Development of Radiopharmaceutical for Mitochondrial Function diagnosis
全件表示
MISC (79件)：
Naoki Kanegawa, Yasushi Kiyono, Taku Sugitaa, Yuji Kuge, Yasushisa Fujibayasi, Hideo Saji. Norepinephrine Transporter Imaging in the Brain of a Rat Model of Depression Using Radioiodinated (2S, alpha S)-2-(alpha-(2-iodophenoxy)benzyl)morpholine. MOLECULAR IMAGING. 2012. 11. 4. 280-285
Evaluation of radiobromine-labeled (2S,αS)-2-(α-(2-bromophenoxy)benzyl)morpholine as an imaging probe for brain norepinephrine transporter.Evaluation of radiobromine-labeled (2S,αS)-2-(α-(2-bromophenoxy)benzyl)morpholine as an imaging probe for brain n・・・
(SNM2012 Annual Meeting 2012)
Evaluation of 5-[<SUP>77</SUP>Br]bromo-4’-thio-2’-deoxyuridine as a radiopharmaceutical for DNA targeted nanoirradiation therapy.
(SNM2012 Annual Meeting 2012)
Evaluation of radiolabeled acetate uptake as surrogate marker for fatty acid synthase expression and therapeutic effects of orlistat in human prostate carcinoma cells.
(SNM2012 Annual Meeting 2012)
Evaluation of <SUP>64</SUP>Cu-ATSM for an internal radiotherapy agent against CD133<SUP>+</SUP> cancer stem cells with human colon carcinoma: <SUP>64</SUP>Cu-ATSM treatment caused cell apoptosis.
(SNM2012 Annual Meeting 2012)
